Skip to main content
MRT Inc. logo

MRT Inc. — Investor Relations & Filings

Ticker · 6034 ISIN · JP3167260003 T Administrative and support service activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-03-28 Governance Information
Country JP Japan
Listing T 6034

About MRT Inc.

https://medrt.co.jp/

MRT Inc. operates a comprehensive online medical information platform that connects medical professionals with healthcare institutions. The company's primary focus is on medical human resources, providing personnel matching and placement services for physicians and other medical staff. Its offerings cater to both part-time and full-time employment needs, including career transition support and recruitment assistance. Through its platform, MRT Inc. also delivers telemedicine support services, aiming to facilitate the provision of safe and high-quality medical care.

Recent filings

Filing Released Lang Actions
内部統制報告書－第26期(2024/01/01－2024/12/31)
Governance Information Classification · 1% confidence The document explicitly states in the header section ("【提出書類】") that it is an "内部統制報告書" (Internal Control Report). It also cites the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act), which mandates the filing of an Internal Control Report by listed companies in Japan. The content discusses the framework, scope, and results of the internal control assessment as of the fiscal year-end (2024年12月31日). This document type is a specific regulatory filing related to internal controls over financial reporting, which aligns best with the general category for regulatory filings that are not explicitly covered by other specific codes like 10-K (Annual Report) or IR (Interim Report). Given the specific nature of an Internal Control Report in the Japanese context, and the lack of a dedicated code for it, the most appropriate classification among the provided options is RNS (Regulatory Filings), as it is a mandatory regulatory submission not fitting the other definitions precisely (it's not a full 10-K, an ER, or an AR/Audit Report in the strict sense, but a specific control assessment). However, since the document is a comprehensive, formal report required by law, and not just an announcement of a report (Rule 2), it should be classified as a specific filing type if possible. Since 'Internal Control Report' is not listed, and it is a formal, comprehensive report, it is a specific regulatory filing. In many contexts, this type of filing is grouped under general regulatory disclosures. Given the options, RNS is the best fit as a mandatory regulatory disclosure that isn't an Annual Report (10-K) or an Interim Report (IR).
2025-03-28 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type, as they do not contain the actual financial statements themselves. FY 2024
2025-03-28 Japanese
有価証券報告書－第26期(2024/01/01－2024/12/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and business information for the fiscal year ending December 31, 2024. This corresponds to the 10-K equivalent in the provided classification schema. FY 2024
2025-03-28 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)". This document details the acquisition of the company's own shares (treasury stock) during a specific reporting period (February 17, 2025, to February 28, 2025). This directly corresponds to the definition of a report on the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a detailed report, not just an announcement of a report.
2025-03-03 Japanese
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Audit Report / Information Classification · 1% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for the fiscal year 2023, including the balance sheet (Bilanz) and notes (Anhang). It details the company's financial position, accounting methods, and board composition. While it is not a full 10-K (which is a specific US SEC filing), it serves the exact function of an Annual Report for a German entity. Given the provided categories, '10-K' is the standard classification for comprehensive annual financial reports. FY 2023
2025-01-22 German
有価証券届出書（組込方式）
Capital/Financing Update Classification · 1% confidence The document is titled "有価証券届出書" (Securities Registration Statement) on the cover page, submitted to the Kanto Local Finance Bureau. It details the issuance of new shares (270,000 common shares) via a third-party allotment to Itochu Corporation, including the offering price, use of proceeds, and details of the allottee. This structure and content are characteristic of a registration statement filed in Japan for a public offering or allotment of securities, which corresponds to the regulatory filing category for comprehensive registration documents. In the context of the provided definitions, this document is a formal regulatory filing related to capital raising (share issuance/allotment). While it involves capital changes (SHA) and financing (CAP), the document itself is the official registration statement required by securities law for such an offering. In the Japanese context, this type of filing is often classified under broader regulatory disclosure categories. Given the options, 'CAP' (Capital/Financing Update) is highly relevant due to the focus on the third-party allotment, but 'RNS' (Regulatory Filings) is the general category for official regulatory submissions that don't fit the highly specific operational reports. However, since this is a comprehensive filing detailing the terms of a capital increase, 'CAP' is a strong candidate if the system prioritizes the *subject matter* over the *form type* when a specific form type isn't listed (like 'S-1' or 'F-1'). Reviewing the definitions: - CAP: Updates on company fundraising, financing activities, or capital structure changes. This document is the core document for a financing activity (third-party allotment). - SHA: Announcement regarding new share issues, stock splits, or other capital changes. This document *contains* the details of a new share issue. - RNS: General regulatory announcements and fallback category. Since the document is a full Securities Registration Statement detailing a capital increase (third-party allotment), it is fundamentally a document about a financing activity. In many classification schemes, a detailed registration statement for a capital raise is categorized by the nature of the transaction. 'CAP' fits the description of 'fundraising' and 'financing activities' best among the specific codes, even though it is also a formal regulatory filing. Given the high level of detail regarding the offering price, use of proceeds, and allotment, it goes beyond a simple 'SHA' announcement or a brief 'RPA'. I will classify it as 'CAP' as it is the primary purpose of the filing, while acknowledging it is also a regulatory document.
2024-11-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.